J&J’s Q2 Consumer Sales Rise 1.7%

Johnson & Johnson’s (J&J) corporate sales rose 1.95% to $18.8 billion for the second quarter of 2017. According to the company, domestic OTC and Neutrogena beauty products helped offset poor performance in baby care for the quarter.

Worldwide consumer division sales increased 1.7% to $3.5 billion. Domestic sales rose  7.4% while international sales fell 2.2%, according to the company.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters